Human Embryonic Stem Cell Therapy in Crohn’s Disease: A Case Report

“Crohn’s disease is a chronic inflammatory disease of the intestines, mainly the colon and ileum, related to ulcers and fistulae. It is estimated to affect 565 000 people in the United States. Currently available therapies, such as antibiotics, thiopurines, and anti-tumor necrosis factor-alpha agents, are only observed to reduce the complications associated with Crohn’s disease and to improve quality of life, but cannot cure the disease. Stem cell therapy appears to have certain advantages over conventional therapies. Our study aimed to evaluate the efficacy of human embryonic stem cell therapy in a patient with Crohn’s disease
Human embryonic stem cell therapy might serve as a new optimistic treatment approach for Crohn’s disease”